Deutsche Bank says the firm’s channel checks suggest “broad and growing interest” in cheaper remanufactured instruments at robotics programs. Intuitive’s instruments and accessories franchise, which represents 60% of its total sales, are at risk by remanufactured da Vinci instruments over the next few years, the analyst tells investors in a research note. Deutsche expects “significant and growing engagement” with remanufacturers by larger hospital systems. It keeps a Sell rating on Intuitive Surgical (ISRG) shares with a $440 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical weakness attributed to Surgical Science comments
- Intuitive Surgical selloff brings attractive opportunity, says Leerink
- Intuitive Surgical’s New Study: A Closer Look at the Ion Endoluminal System
- Intuitive Surgical’s Strong Performance and Growth Potential Reinforce Buy Rating
- Intuitive Surgical’s Earnings Call: Growth Amid Challenges
